News

GENOMEWEB–Liquid Biopsy of HPV DNA Shows Promise for Monitoring Remission in Oral Cancer

Liquid Biopsy of HPV DNA Shows Promise for Monitoring Remission in Oral Cancer Oct 25, 2018 | Molika Ashford NEW YORK (GenomeWeb) – Investigators shared data this week from a small prospective trial of a blood-based method they developed to test patients with human papillomavirus-associated oral cancers for signs of remission or recurrence. The approach, which was spearheaded by researchers at the University of North Carolina and is being commercialized by startup Naveris, would potentially allow doctors to more accurately…

0
Read More

MEDSCAPE–Liquid Biopsy Confirms Remission in HPV Oropharyngeal Cancer

Liquid Biopsy Confirms Remission in HPV Oropharyngeal Cancer Roxanne Nelson, BSN, RN October 24, 2018 The so-called liquid biopsy holds great promise for detecting a variety of cancers more accurately, guiding individualized therapy, and improving monitoring during treatment. New data suggest that testing for plasma circulating tumor human papillomavirus DNA (ctHPVDNA) can be an effective method of surveillance for patients with p16-positive oropharyngeal squamous cell carcinoma (OPSCC). The performance of an optimized multianalyte ctHPVDNA blood test for detecting cancer recurrence was “exceptional,”…

0
Read More

Naveris Congratulates Scientific Advisors Bhisham Chera and Gaorav Gupta on Presentation of Clinical Data at the 2018 ASTRO Annual Meeting

“WALTHAM, Mass., Oct. 22, 2018 /PRNewswire/ — Naveris, Inc., a private biotechnology company developing blood tests for early cancer detection, congratulates Bhisham Chera, M.D. and Gaorav Gupta, M.D., Ph.D., scientific advisors and co-chairs of its Scientific Advisory Board, and announces the presentation of clinical trial data at the American Society for Radiation Oncology annual meeting being held October 21 to October 24, 2018, in San Antonio, TX.” Read the full article on PRNewsWire.com.

0
Read More